1887

Abstract

Hepatitis B virus (HBV) infection is a global public health problem with about 257 million chronically infected people and over 887000 deaths annually. In this study, 32 whole HBV genomes of various genotypes were amplified from clinical isolates to create transfection clones. The clones were sequenced, and their biological properties characterized by transfecting linear HBV clones into HepG2 cells. We analysed the SPI and SPII promotor regions, X-gene, BCP/PC sequences, core, preS/S and HBV polymerase sequences. HBV clones analysed in this study revealed differential replication kinetics of viral nucleic acids and expression of proteins. Sequence analysis of HBV clones revealed mutations in preS1, preS2 and S genes; deletion and insertion and point mutations in BCP/PC region; including novel and previously reported mutations. Among the patient samples tested, HBV genotype B clones were more likely to have higher frequencies of mutations, while sub-genotype A1 and A2 clones tended to have fewer mutations. No polymerase drug resistant mutations were seen. HBeAg mutations were primarily in the BCP/PC region in genotype B, but core truncations were found in genotype E. S gene mutations affecting HBsAg expression and detection were seen in all genotypes except A2. Using an HBV clone with repetitive terminal sequences and a I restriction site allowed us to analyse HBV analyte production in cell culture and characterize the genetics of viral phenotypes using complete HBV genomes isolated from serum/plasma samples of infected patients.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001675
2021-11-01
2024-05-08
Loading full text...

Full text loading...

References

  1. World Health Organisation Global Hepatitis Report, 2017 Geneva: World Health Organization; 2017
    [Google Scholar]
  2. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet 2016; 388:1081–1088 [View Article] [PubMed]
    [Google Scholar]
  3. Nassal M. Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology 1999; 42:100–116 [View Article] [PubMed]
    [Google Scholar]
  4. Arankalle VA, Gandhe SS, Borkakoty BJ, Walimbe AM, Biswas D. A novel HBV recombinant (Genotype I) similar to Vietnam/Laos in a primitive tribe in Eastern India. J Viral Hepat 2010; 17:501–510 [View Article] [PubMed]
    [Google Scholar]
  5. Arauz-Ruiz P, Hn N, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002; 83:2059–2073 [View Article]
    [Google Scholar]
  6. Chu C-J, Keeffe EB, Han S-H, Perrillo RP, Min AD. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003; 125:444–451 [View Article] [PubMed]
    [Google Scholar]
  7. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B. J Med Virol 2008; 80:27–46 [View Article]
    [Google Scholar]
  8. Kramvis A. Genotypes and genetic variability of hepatitis B. Intervirology 2014; 57:141–150 [View Article]
    [Google Scholar]
  9. Velkov S, Ott JJ, Protzer U, Michler T. The global hepatitis B virus genotype distribution approximated from available genotyping data. Genes 2018; 9:495 [View Article]
    [Google Scholar]
  10. Chu C-J, Lok ASF. Clinical significance of Hepatitis B virus genotypes hepatology; 2002; 351274–1276
  11. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995; 38:24–34 [View Article] [PubMed]
    [Google Scholar]
  12. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003; 46:329–338 [View Article] [PubMed]
    [Google Scholar]
  13. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988; 69:2575–2583 [View Article] [PubMed]
    [Google Scholar]
  14. Tong S, Li J, Vitvitski L, Benjelloun S, Trepo C. Rapid screening for bacterial colonies harbouring tandem hepatitis B virus sequences by an oligonucleotide probe. J Virol Methods 1991; 32:109–114 [View Article] [PubMed]
    [Google Scholar]
  15. Gunther S, Li BC, Miska S, Kruger DH, Meisel H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69:5437–5444 [View Article] [PubMed]
    [Google Scholar]
  16. Gunther S, Sommer G, Von Breunig F, Iwanska A, Kalinina T. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 1998; 36:531–538 [View Article] [PubMed]
    [Google Scholar]
  17. Salisse J, Sureau C. A function essential to viral entry underlies the hepatitis B virus A. J Virol 2009; 83:9321–9328 [View Article] [PubMed]
    [Google Scholar]
  18. Blum HE. Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. Digestion 1995; 56:85–95 [View Article] [PubMed]
    [Google Scholar]
  19. Messageot F, Salhi S, Eon P, Rossignol J-M. Proteolytic processing of the hepatitis B virus E antigen precursor. Cleavage at two furin consensus sequences. J Biol Chem 2003; 278:891–895 [View Article]
    [Google Scholar]
  20. Schödel F, Peterson D, Zheng J, Jones JE, Hughes JL et al. Structure of Hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem 1993; 268:1332–1337 [View Article] [PubMed]
    [Google Scholar]
  21. Beames B, Lanford RE. Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA. Virology 1993; 194:597–607 [View Article] [PubMed]
    [Google Scholar]
  22. Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol 2010; 84:12850–12861 [View Article] [PubMed]
    [Google Scholar]
  23. Salpini R, Colagrossi L, Bellocchi MC, Surdo M, Becker C et al. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology 2015; 61:8823–8833 [View Article]
    [Google Scholar]
  24. Forbi JC, Vaughan G, Purdy MA, Campo DS, Xia GL. Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS ONE 2010; 5:e11615 [View Article] [PubMed]
    [Google Scholar]
  25. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nuc Acids Symp Ser 1999; 41:95–98
    [Google Scholar]
  26. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109:121–124 [View Article] [PubMed]
    [Google Scholar]
  27. Mixson-Hayden T, Lee D, Ganova-Raeva L, Drobeniuc J, Stauffer WM. Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa. Am J Trop Med Hyg 2014; 90:1014–1020 [View Article] [PubMed]
    [Google Scholar]
  28. Zhang YL, Cheng T, Cai YJ, Yuan Q, Liu C. RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiol 2010; 10:214 [View Article] [PubMed]
    [Google Scholar]
  29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402–408 [View Article] [PubMed]
    [Google Scholar]
  30. Core Team R. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2018 https://www.R-project.org/
  31. Ogura S, Tameda M, Sugimoto K, Ikejiri M, Usui M. A substitution in the pre-S1 promoter region is associated with the viral regulation of hepatitis B virus. Virol J 2019; 16:59 [View Article] [PubMed]
    [Google Scholar]
  32. Hao R, Xiang K, Shi Y, Zhao D, Tian H et al. Naturally occurring mutations within HBV surface promoter ii sequences affect transcription activity, HBsAg and HBV DNA levels in HBeAg-positive chronic hepatitis B patients. Viruses 2019; 11:78
    [Google Scholar]
  33. Slagle BL, Bouchard MJ. Hepatitis B virus X and regulation of viral gene expression. Cold Spring Harb Perspect Med 2016; 6:a021402 [View Article] [PubMed]
    [Google Scholar]
  34. Wang X-L, Ren J-P, Wang X-Q, Wang X-H, Yang S-F. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients. World J Gastroenterol 2016; 22:3268–3274 [View Article] [PubMed]
    [Google Scholar]
  35. Lazarevic I. Clinical implications of Hepatitis B virus mutations: recent advances. World J Gastroenterol 2014; 20:7653–7664 [View Article] [PubMed]
    [Google Scholar]
  36. Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 2008; 23:474–481 [View Article] [PubMed]
    [Google Scholar]
  37. Curtis M, Zhu Y, Borroto-Esoda K. Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir. J Infect Dis 2007; 196:1483–1486 [View Article] [PubMed]
    [Google Scholar]
  38. Choi Y-M, Lee S-Y, Kim B-J. Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression. World J Gastroenterol 2018; 24:1708–1724 [View Article] [PubMed]
    [Google Scholar]
  39. Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 2016; 22:145–154 [View Article] [PubMed]
    [Google Scholar]
  40. Hollinger FB. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 2007; 14:11–15 [View Article] [PubMed]
    [Google Scholar]
  41. Gencay M, Hubner K, Gohl P, Seffner A, Weizenegger M. Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population. PLoS ONE 2017; 12:e0172101 [View Article] [PubMed]
    [Google Scholar]
  42. Malagnino V, Salpini R, Maffongelli G, Battisti A, Fabeni L. High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance. PLoS ONE 2018; 13:e0195045 [View Article] [PubMed]
    [Google Scholar]
  43. Malve B, Eschlimann M, Galgey S, Fenaux H, Zoulim F. Impact of deletions and mutations in hepatitis B virus envelope proteins on serological profile and clinical evolution. Virus Res 2017; 238:141–147 [View Article] [PubMed]
    [Google Scholar]
  44. Wang H-C, Huang W, Lai M-D, Su I-J. Hepatitis B virus Pre-s mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 2006; 97:683–688 [View Article] [PubMed]
    [Google Scholar]
  45. Funk ML, Rosenberg DM, ASF L. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002; 9:52–61 [View Article] [PubMed]
    [Google Scholar]
  46. Liao Y, Hu X, Chen J, Cai B, Tang J. Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. PLoS ONE 2012; 7:e38394 [View Article] [PubMed]
    [Google Scholar]
  47. Purdy MA, Gonzales AC, Dimitrova Z, Khudyakov Y. Supragenotypic groups of the Hepatitis B Virus Genome. J Gen Virol 2008; 89:1179–1183 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001675
Loading
/content/journal/jgv/10.1099/jgv.0.001675
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error